WallStreetZenWallStreetZen

NASDAQ: IRD
Opus Genetics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Opus Genetics earnings were -$68.2M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest IRD earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$17.5M, up 135.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IRD reported annual earnings of -$57.5M, with 476.1% growth. The next IRD earnings date is Feb 25, 2026.

IRD earnings history

Current Revenue
$14.6M
Current Earnings
-$68.2M
Current Profit Margin
-466.1%

IRD Return on Equity

Current Company
-774.2%
Current Industry
-21.2%
Current Market
35.1%
IRD's Return on Equity (-774.2%)... subscribe to Premium to read more.
High Return on Equity Performance

IRD Return on Assets

Current Company
-170.7%
Current Industry
-8.8%
IRD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IRD announces earnings.

IRD Return on Capital Employed

Current Company
-968.51%
Current Industry
-3.5%
IRD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IRD vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IRD-$68.09M-$68.20MN/A-$1.88
MIST-$54.13M-$58.01MN/A-$0.82
IPSC-$9.95M-$26.48MN/A-$0.32
IPHA-$46.80M-$54.18MN/A-$0.65
TLSA-$16.62M-$11.86MN/A-$0.11
View Top Biotech Stocks

IRD earnings dates

Next earnings date
Feb 25, 2026

Opus Genetics Earnings Reports & History FAQ

What were Opus Genetics's earnings last quarter?

On IRD's earnings call on Invalid Date, Opus Genetics (NASDAQ: IRD) reported Q3 2025 earnings per share (EPS) of -$0.25, up 13.79% year over year. Total IRD earnings for the quarter were -$17.45 million. In the same quarter last year, Opus Genetics's earnings per share (EPS) was -$0.29.

If you're new to stock investing, here's how to buy Opus Genetics stock.

When does Opus Genetics report earnings?

The next IRD earnings call is Invalid Date. Add IRD to your watchlist to be reminded of Opus Genetics's next earnings date.

Is Opus Genetics profitable or losing money?

As of the last Opus Genetics earnings report, Opus Genetics is currently losing money. Opus Genetics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$68.20 million, a 150.82% increase year over year.

What was IRD's earnings growth in the past year?

As of Opus Genetics's earnings date in Invalid Date, Opus Genetics's earnings has grown year over year. IRD earnings in the past year totalled -$68.20 million.

What are Opus Genetics's earnings expectations?

The current EPS estimate for Opus Genetics's earnings report in Invalid Date is -$0.12.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.